ArticleThoracic cancer2026

Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

Min Seok Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.